Results 291 to 300 of about 12,182,524 (404)

Bone disease and oromaxillofacial disorders: a cross- sectional study in a Tanzanian pediatric population. [PDF]

Orphanet J Rare Dis
Mashala EI, Brunet-Llobet L, Lapitskaya A, Balsells-Mejía S, Mrina O, Miranda-Rius J.   +5 more
europepmc   +1 more source

Secondary disease in irradiated mice grafted with allogeneic bone marrow from antilymphocyte serum-treated donors

, 1969
G. D. Ledney, D. W. van Bekkum
openalex   +1 more source

Contributions of the host microenvironment to cancer-induced bone disease.

Cancer Research, 2014
S. Olechnowicz, C. Edwards
semanticscholar   +1 more source

Thermoresponsive BrushGel Microcarriers for Efficient Cell Expansion and Enzyme‐Reduced Harvesting

Advanced Healthcare Materials, EarlyView.
Askari et al, report on temperature‐responsive microcarriers to minimize enzyme use and cost in dynamic cultures. Abstract Scaling up cell therapy requires efficient expansion of high‐quality cells. Microcarrier(MC)‐based systems offer high surface‐to‐volume ratios and reduce culture media usage.
Esfandyar Askari, Mahdieh Shokrollahi Barough, Amir Seyfoori, Mahmood Razzaghi, Joel Alexander Ninan, Aidan B. P. Murray, Mahmoud Salkhordeh, Yuan Tan, Shirley H. J. Mei, Mohsen Akbari   +9 more
wiley   +1 more source

Bone cement implantation syndrome in patients with cemented endoprostheses for metastatic bone disease in the femur. [PDF]

J Bone Oncol
Ladegaard TH, Stensballe J, Petersen MM, Sørensen MS.   +3 more
europepmc   +1 more source

The effects of bortezomib on bone disease in patients with multiple myeloma

Cancer, 2014
M. Mohty, F. Malard, B. Mohty, B. Savani, P. Moreau, E. Terpos   +5 more
semanticscholar   +1 more source

Gasotransmitters in Modern Medicine: Promises and Challenges in the Use of Porous Crystalline Carriers

Advanced Healthcare Materials, EarlyView.
This perspective provides an overview of the growing interest in utilizing various gasotransmitters—small gaseous signaling molecules namely nitric oxide (NO), carbon monoxide (CO), and hydrogen sulfide (H2S)—for several therapeutic applications, with emphasis on the potential use of porous materials as carriers to provide safe and controlled local ...
Rosana V. Pinto, Moisés L. Pinto, Christian Serre   +2 more
wiley   +1 more source

Endocrine Bone Disease [Abridged]

, 1969
J. A. Parsons, C. J. Robinson
openalex   +1 more source

Recent Applications of Mesoporous Silica Nanoparticles in Gene Therapy

Advanced Healthcare Materials, EarlyView.
The review summarizes the synthesis of mesoporous silica nanoparticles (MSNs) with modifiable surface properties, functionalization strategies, mechanism of therapeutic payload release, and current applications in gene therapy, focusing on their capabilities in the targeted delivery of therapeutic nucleic acids, CRISPR‐Cas systems, and other genetic ...
Tamanna Binte Huq, Punnya Anil Kumar Jeeja, Sudip Kumar Dam, Sabya Sachi Das, Juan L. Vivero‐Escoto   +4 more
wiley   +1 more source

The Design of a Patient-Centered Hierarchal Composite Outcome for a Multi-Center Randomized Controlled Trial in Metastatic Bone Disease. [PDF]

Curr Oncol
Farrukh H, Kunzli A, Virag O, O'Hara N, Sprague S, Cizik A, Gehrke-Becker R, Schubert T, Ghert M.   +8 more
europepmc   +1 more source